Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey (vol 19, pg 151, 2015)

被引：2
|
作者：
Kamal, S. M.
Husain, Md A.
Sultana, S.
Begum, V.
Haque, N.
Ahmed, Md J.
Rahman, A.
Hyder, K. A.
Hossain, Md S.
Rahman, M.
Ahsan, C. R.
Aung, K. J. M.
Islam, Md A.
Hasan, Md R.
Van Deun, A.
机构：
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2015年 / 19卷 / 05期
关键词：
D O I：
10.5588/ijtld.14.0200-e
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：622 / 622
页数：1
相关论文
共 50 条
  • [31] Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan (vol 12, pg 326, 2008)
    Javaid, A.
    Hasan, R.
    Zafar, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (07) : 824 - 824
  • [32] Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study
    Dohal, Matus
    Dvorakova, Vera
    Sperkova, Miluse
    Porvaznik, Igor
    Cabibbe, Andrea Maurizio
    Trovato, Alberto
    Spitaleri, Andrea
    Rasmussen, Erik Michael
    Prso, Kristian
    Skerenova, Maria
    Cirillo, Daniela Maria
    Solovic, Ivan
    Mokry, Juraj
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2022, 26
  • [33] First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey
    Yazisiz, Hatice
    Hircin Cenger, Derya
    Yazisiz, Veli
    Kilic, Lutfiye
    Altin, Sedat
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2019, 67 (02): : 92 - 101
  • [34] Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study (vol 10, e0134597, 2015)
    Scott, James C.
    Shah, Neha
    Porco, Travis
    Flood, Jennifer
    PLOS ONE, 2015, 10 (09):
  • [35] Drug Resistance to Anti-Tuberculosis Drugs: A Cross-Sectional Study From Makkah, Saudi Arabia
    Al-Hayani, Ahmad M.
    Kamel, Shady A.
    Almudarra, Sami S.
    Alhayani, Majed
    Abu-Zaid, Ahmed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [36] Pediatric tuberculosis drug market: an insider perspective on challenges and solutions (vol 19, pg 191, 2015)
    Usherenko, I.
    Roy, U. Basu
    Mazlish, S.
    Liu, S.
    Benkoscki, L.
    Coutts, D.
    Epstein, S.
    Qian, M.
    Rafiq, S.
    Scott, C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (02) : 284 - 284
  • [37] Magnitude of Phenotypic and MTBDRplus Line Probe Assay First-Line Anti-Tuberculosis Drug Resistance Among Tuberculosis Patients; Northwest Ethiopia
    Yigzaw, Wubet Birhan
    Torrelles, Jordi B.
    Wang, Shu-Hua
    Tessenna, Belay
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 497 - 505
  • [38] PREVALENCE AND DRUG RESISTANCE PATTERNS OF ANTI-TUBERCULOSIS DRUGS (ATDS) AMONG NEWLY DIAGNOSED AND PREVIOUSLY TREATED SPUTUM-POSITIVE PATIENTS OF BANGLADESH
    Rahman, Md Mostafizur
    Kamal, S. M. Mostafa
    Hossain, Ali
    Mujtaba, Asif
    Siddiqui, Md Mahmudur Rahman
    Ahasan, Ham Nazmul
    RESPIROLOGY, 2014, 19 : 236 - 236
  • [39] Evaluation Study of xMAP TIER Assay on a Microsphere-Based Platform for Detecting First-Line Anti-Tuberculosis Drug Resistance
    Ou, Xichao
    Zhang, Zhiguo
    Zhao, Bing
    Song, Zexuan
    Wang, Shengfen
    He, Wencong
    Pei, Shaojun
    Liu, Dongxin
    Xing, Ruida
    Xia, Hui
    Zhao, Yanlin
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (24)
  • [40] Epidemiology of first-and second-line anti-tuberculosis drug resistance profile in new pulmonary tuberculosis cases in addis ababa metropolitan area, ethiopia
    Akalu, G. T.
    CLINICA CHIMICA ACTA, 2024, 558 : 55 - 55
12345